Abstract:Background: Disruption of brain circuits, including the basal ganglia network, is one of the core mechanisms of Parkinson’s disease(PD). Understanding the structural connection alterations in PD is the key for relevant treatment. Although, due to methodological limitations, most previous studies suffered from the difficulty of locating white matter damages to specific fiber tracts. In the present study, we aimed to demonstrate tract-specific white matter structural changes and its relationship with clinical symptoms.Methods: Nighty-eight PD patients(41 patients were at early stage and 57 were at middle stage) and 76 healthy controls were enrolled and underwent brain magnetic resonance imaging and neuropsychological tests. We implemented the fixel-based analysis method to investigate both micro- and macro-structural changes in the white matter fibers of PD patients, and to investigate their correlation with clinical symptoms.Findings: We found decreased fiber density(FD) of the corpus callosum and increased FD of the cortical spinal tract in PD patients comparing to healthy controls. We also found increased fiber-bundle cross-section(FC) of the superior cerebellar peduncle of PD patients. Further region-of-interest analysis showed that FD values of the corpus callosum in PD patients were negatively correlated with UPDRS-III scores(r=0.001, p=-0.334), HAMD-17 scores(r=0.043, p=-0.205) and HAMA scores(r=0.02, p=-0.234). Also, log transformed FC values of superior cerebellar peduncle were negatively correlated with HAMD-17 scores(r=0.013, p=-0.251) and positively correlated with MMSE scores(r=0.002, p=0.312). Interpretation: PD patients had both decreased and increased white matter integrity within specific fiber bundles. Additionally, these white matter alterations were different across disease stages, suggesting complex pathological and compensatory changes during the development of PD.Funding Statement: This study was supported by the 13th Five-year Plan for National Key Research and Development Program of China (Grant No. 2016YFC1306600), the Health Foundation for Creative Talents in Zhejiang Province (2016).Declaration of Interests: The authors have no conflicts of interest to declare.Ethics Approval Statement: All the subjects had signed written informed consent forms before participating in the study. This research was approved by the Medical Ethics Committee of 2nd Affiliated Hospital, Zhejiang University.

Synchrotron FTIR Microspectroscopy Study of the Striatum in 6-Hydroxydopamine Rat Model of Parkinson's Disease

[Synchrotron Radiation-Based FTIR Microspectroscopy Study of 6-Hydroxydopamine Induced Parkinson's Disease Cell Model].

[Synchrotron Radiation-Based FTIR Microspectroscopy Study of the Hippocampus of 6-Hydroxydopamine-lesioned Rats].

Differential expression of synaptic proteins in unilateral 6-OHDA lesioned rat model-A comparative proteomics approach.

Cortical Regulation of Striatal Projection Neurons and Interneurons in a Parkinson's Disease Rat Model.

Protein Profiling of Striatum and Substantia Nigra from Hemiparkinsonian Rat Model by Offgel-Hplc-Ms/Ms

Functional Changes in the Frontal Cortex in Parkinson’s Disease Using a Rat Model

Time Course Study of Fractional Anisotropy in the Substantia Nigra of A Parkinsonian Rat Model Induced by 6-Ohda

Alterations in 5-HT2A receptor binding in various brain regions among 6-hydroxydopamine-induced Parkinsonian rats.

Proton Magnetic Resonance Spectroscopic Changes in the Striatum in Rat Model of Parkinson's Disease

In Vivo Detection of Metabolic Changes in the Striatum of Proteasomal Inhibition-Induced Parkinson's Disease in Rats Using Proton MR Spectroscopy at 9.4 T.

Effects of L-dopa on Cells Expressing D2 Receptors and Level of Dopamine Transmitter in Hemiparkinsonian Rats

Alterations in 5-HT<sub>2A</sub>receptor binding in various brain regions among 6-hydroxydopamine-induced Parkinsonian rats

Spatiotemporal Neurodegeneration of the Substantia Nigra and Its Connecting Cortex and Subcortex in Parkinson's Disease.

[A study of microPET for assessing regional cerebral glucose metabolism and the expression of dopamine receptor type 2 in a rat model of Parkinson's disease].

Parkinson's Disease: in Vivo Metabolic Changes in the Frontal and Parietal Cortices in 6-OHDA Treated Rats During Different Periods.

Fiber-Specific White Matter Alterations in Parkinson's Disease

The Effects of Unilateral 6-OHDA Lesion in Medial Forebrain Bundle on the Motor, Cognitive Dysfunctions and Vulnerability of Different Striatal Interneuron Types in Rats

Upregulation of γ-synuclein in the prefrontal cortex and hippocampus following dopamine depletion: A study using the striatal 6-hydroxydopamine hemiparkinsonian rat model

Differential Proteome of the Striatum from A30P &#X03b1;-Synuclein Transgenic Mouse Model of Parkinson's Disease

Neuronal activity and expression of 5-HT1A receptor of medial prefrontal cortex in rats model with parkinson's disease